Taylor R, Heaton A, Hetherington C S, Alberti K G
Metabolism. 1986 May;35(5):430-5. doi: 10.1016/0026-0495(86)90133-2.
In order to investigate the cellular mechanisms of the insulin resistance displayed by subjects with chronic renal failure, adipocyte insulin receptor status and in vitro insulin sensitivity were studied. Adipocytes from uremic subjects displayed normal maximum specific insulin binding (2.55 +/- 0.23 v 2.57 +/- 0.09% per 10 cm2 cell membrane, although half-maximum binding was observed at 91 +/- 8 (uremic) and 139 +/- 11 (control) pmol/L (P less than 0.005). In six subjects restudied after three months of continuous ambulatory peritoneal dialysis, maximum specific insulin binding fell as a consequence of changes in both receptor affinity and number (2.87 +/- 0.20 v 2.05 +/- 0.17% per 10 cm2 cell membrane, P less than 0.01). Basal and maximal rates of lipogenesis were similar in the uremic and control groups, and half-maximal stimulation occurred at 13.5 +/- 4.4 and 21.4 +/- 3.0 pmol/L, respectively (NS). During continuous ambulatory peritoneal dialysis, adipocyte insulin sensitivity did not change significantly as assessed by stimulation of lipogenesis or glucose uptake (half-maximal stimulation at 12.0 +/- 4.0 v 26.4 +/- 11.0 and 23.1 +/- 7.1 v 29.0 +/- 7.5 pmol/L, before and during dialysis, respectively). These data suggest either that adipose tissue and muscle display differential insulin sensitivities in chronic renal failure or that other factors such as circulating inhibitors of insulin action are not detected by in vitro assays.
为了研究慢性肾衰竭患者所表现出的胰岛素抵抗的细胞机制,对脂肪细胞胰岛素受体状态和体外胰岛素敏感性进行了研究。尿毒症患者的脂肪细胞显示出正常的最大特异性胰岛素结合能力(每10平方厘米细胞膜为2.55±0.23对2.57±0.09%),尽管半最大结合出现在91±8(尿毒症组)和139±11(对照组)皮摩尔/升(P<0.005)。在6名接受持续非卧床腹膜透析3个月后重新研究的患者中,由于受体亲和力和数量的变化,最大特异性胰岛素结合能力下降(每10平方厘米细胞膜为2.87±0.20对2.05±0.17%,P<0.01)。尿毒症组和对照组的基础和最大脂肪生成率相似,半最大刺激分别出现在13.5±4.4和21.4±3.0皮摩尔/升(无显著性差异)。在持续非卧床腹膜透析期间,通过脂肪生成或葡萄糖摄取刺激评估,脂肪细胞胰岛素敏感性没有显著变化(透析前和透析期间半最大刺激分别为12.0±4.0对26.4±11.0以及23.1±7.1对29.0±7.5皮摩尔/升)。这些数据表明,要么在慢性肾衰竭中脂肪组织和肌肉表现出不同的胰岛素敏感性,要么体外试验未检测到其他因素,如胰岛素作用的循环抑制剂。